Jang David H, Khatri Utsha G, Shortal Brenna P, Kelly Matthew, Hardy Kevin, Lambert David S, Eckmann David M
Department of Emergency Medicine, Division of Medical Toxicology and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, John Morgan Building, 3620 Hamilton Walk, Philadelphia, 19104, PA, USA.
Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.
Intensive Care Med Exp. 2018 Jan 30;6(1):4. doi: 10.1186/s40635-018-0169-2.
Carbon monoxide (CO) poisoning is the leading cause of poisoning mortality and morbidity in the USA. Carboxyhemoglobin (COHb) levels are not predictive of severity or prognosis. At this time, the measurement of mitochondrial respiration may serve as a biomarker in CO poisoning. The primary objective of this study was to assess changes in mitochondrial function consisting of respiration and generation of reactive oxygen species (ROS) in peripheral blood mononuclear cells (PBMCs) obtained from patients with CO poisoning.
PBMCs from patients having confirmed CO exposure treated with hyperbaric oxygen or HBO (CO group) and healthy controls (control group) were analyzed with high-resolution respirometry. PBMCs were placed in a 2-ml chamber at a final concentration of 3-4 × 10 cells/ml to simultaneously obtain both respiration and hydrogen peroxide (HO) production. In the CO group, we performed measurements before and after patients underwent their first HBO treatment.
We enrolled a total of 17 subjects, including 7 subjects with confirmed CO poisoning and 10 subjects in the control group. The CO group included five (71.4%) men and two (28.6%) women having a median COHb of 28%. There was a significant decrease in respiration as measured in pmol O × s × 10 PBMCs in the CO group (pre-HBO) when compared to the control group: maximal respiration (18.4 ± 2.4 versus 35.4 ± 2.8, P < 0.001); uncoupled Complex I respiration (19.8 ± 1.8 versus 41.1 ± 3.8, P < 0.001); uncoupled Complex I + II respiration (32.3 ± 3.2 versus 58.3 ± 3.1, P < 0.001); Complex IV respiration (43.5 ± 2.9 versus 63.6 ± 6.31, P < 0.05). There were also similar differences measured in the CO group before and after HBO treatment with an overall increase in respiration present after treatment. We also determined the rate of HO production simultaneously with the measurement of respiration. There was an overall significant increase in the HO production in the CO group after HBO treatment when compared to prior HBO treatment and the control group.
In this study, PBMCs obtained from subjects with CO poisoning have an overall decrease in respiration (similar HO production) when compared to controls. The inhibition of Complex IV respiration is from CO binding leading to a downstream decrease in respiration at other complexes. PBMCs obtained from CO-poisoned individuals immediately following initial HBO therapy displayed an overall increase in both respiration and HO production. The study findings demonstrate that treatment with HBO resulted in improved cellular respiration but a higher HO production. It is unclear if the increased production of HO in HBO treatment is detrimental.
在美国,一氧化碳(CO)中毒是中毒致死和发病的主要原因。碳氧血红蛋白(COHb)水平无法预测中毒的严重程度或预后。目前,线粒体呼吸的测量可作为CO中毒的生物标志物。本研究的主要目的是评估从CO中毒患者获取的外周血单核细胞(PBMC)中线粒体功能的变化,包括呼吸作用和活性氧(ROS)的产生。
对经高压氧治疗(HBO)的确诊CO暴露患者(CO组)和健康对照者(对照组)的PBMC进行高分辨率呼吸测定分析。将PBMC以3 - 4×10⁶细胞/ml的终浓度置于2 ml反应室中,以同时获取呼吸作用和过氧化氢(H₂O₂)的产生情况。在CO组中,于患者接受首次HBO治疗前后进行测量。
我们共纳入17名受试者,其中包括7名确诊CO中毒的患者和10名对照组受试者。CO组包括5名男性(71.4%)和2名女性(28.6%),COHb中位数为28%。与对照组相比,CO组(HBO治疗前)以pmol O₂×s⁻¹×10⁶ PBMCs测量的呼吸作用显著降低:最大呼吸作用(18.4±2.4对35.4±2.8,P < 0.001);解偶联复合体I呼吸作用(19.8±1.8对41.1±3.8,P < 0.001);解偶联复合体I + II呼吸作用(32.3±3.2对58.3±3.1,P < 0.001);复合体IV呼吸作用(43.5±2.9对63.6±6.31,P < 0.05)。HBO治疗前后的CO组也有类似差异,治疗后呼吸作用总体增加。我们还在测量呼吸作用的同时测定了H₂O₂的产生速率。与HBO治疗前及对照组相比,CO组在HBO治疗后H₂O₂的产生总体显著增加。
在本研究中,与对照组相比,从CO中毒受试者获取的PBMC呼吸作用总体降低(H₂O₂产生情况相似)。复合体IV呼吸作用的抑制是由于CO结合导致其他复合体下游呼吸作用降低。在首次HBO治疗后立即从CO中毒个体获取的PBMC显示呼吸作用和H₂O₂产生均总体增加。研究结果表明,HBO治疗可改善细胞呼吸作用,但H₂O₂产生增加。尚不清楚HBO治疗中H₂O₂产生增加是否有害。